BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/72/0.1/20.12.24 | Market Closed - Bid/Ask 11:21:40 01/07/2024 pm IST | After market 11:46:54 pm | |||
| 0.129 EUR | +34.38% |
|
0.135 | +4.65% |
| 1 month | -44.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 01/24/01 | 0.129 | +34.38% |
| 28/24/28 | 0.096 | -1.03% |
| 27/24/27 | 0.097 | -14.16% |
| 26/24/26 | 0.113 | -9.60% |
| 25/24/25 | 0.125 | +5.93% |
Real-time Boerse Frankfurt Warrants
Last update July 01, 2024 at 11:21 pm IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VD3R9A |
| ISIN | DE000VD3R9A3 |
| Date issued | 09/04/2024 |
| Strike | 72 $ |
| Maturity | 20/12/2024 (172 Days) |
| Parity | 10 : 1 |
| Emission price | 0.19 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.31 € |
|---|---|
| Lowest since issue | 0.096 € |
| Delta | -0.04x |
| Omega | 4.469 |
| Premium | 49.29x |
| Gearing | 105.61x |
| Moneyness | 0.5165 |
| Difference Strike | -18.3 $ |
| Difference Strike % | -25.42% |
| Spread | 0.01 € |
| Spread % | 7.81% |
| Theoretical value | 0.1350 |
| Implied Volatility | 68.31 % |
| Total Loss Probability | 89.04 % |
| Intrinsic value | 0.000000 |
| Present value | 0.1350 |
| Break even | 70.55 € |
| Theta | -0.01x |
| Vega | 0.01x |
| Rho | -0x |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
92.37
USD
Average target price
96.05
USD
Spread / Average Target
+3.99%
- Stock Market
- Warrants
- Warrant
